| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |